Advances in the Management of Prostate, Kidney, and Bladder Cancers 2023

Friday, September 29, 2023, 12:00 PM - Saturday, September 30, 2023, 4:50 PM, Marriott Georgetown, Washington, DC


MedStar Health is proud to present this blended conference to bring you the most up-to-date comprehensive care and education for the kidney, bladder, and prostate. During this meeting, you can attend high-caliber lectures with questions and discussion time focusing on these three cancer areas. Expert faculty will deliver state-of-the-art lectures that will include treatment approaches, clinical trials, biologic and genomic factors, and future directions. Presentations will also discuss emerging controversies and ongoing research aimed at addressing them. Advances in Prostate Cancer reviews recent advances in the diagnosis and treatment of patients with localized and advanced prostate cancer. Key clinical topics will include the use of biomarkers and modern imaging technologies in the management of early-stage prostate cancer as well as advances in the multidisciplinary approach to patients with high-risk, locally advanced, relapsed non-metastatic, and metastatic prostate cancer. Applications of new therapeutic agents, cutting-edge radiation technology, combined modality strategies, and evolving minimally invasive urologic surgical approaches will also be discussed. Advances in Kidney Cancer will review the approaches to the treatment of patients with small renal masses and the role of cytoreductive nephrectomy and an update on adjuvant therapy. Expert speakers will also present the latest front line and subsequent systemic therapy approaches as well as the treatment of patients with non-clear cell RCC. Advances in Bladder Cancer is a comprehensive session that explores the latest advances in bladder cancer diagnosis, management, and treatment. With a focus on innovative approaches and emerging therapies, participants will gain valuable insights into various aspects of bladder cancer care. During the lectures, it will covers a range of topics, including BCG unresponsive non-muscle invasive bladder cancer, management strategies for muscle invasive bladder cancer, and cutting-edge developments in bladder cancer surgery. Additionally, the talks delves into clinical trials, upper tract urothelial carcinoma, and advances in systemic therapy for metastatic urothelial carcinoma, ensuring a well-rounded understanding of the current bladder cancer landscape. These talks were designed for healthcare professionals, researchers, and students who are looking to enhance their knowledge and stay up-to-date with the latest developments in the field of bladder cancer care.

1. Identify the roles and responsibilities of members of the healthcare team involved in the collaborative care of patients with prostate, kidney, and bladder cancers.
2. Describe emerging treatments, endpoints, and predictive biomarkers for RCC management.
3. Describe the role of immunotherapy and novel targeted therapies for upper tract and chemotherapy-refractory carcinoma.
4. Describe symptom management, supportive care, procedural, and pharmacological basis of treating prostate and bladder cancers.
5. Integrate a team-based approach in the care of patients with prostate, kidney, and bladder cancers.
6. Discuss the current treatment algorithm for patients with metastatic clear cell and non-clear cell RCC.
7. Describe the evolving role of surgery in the management of patients with all stages of kidney cancer.
8. Discuss the evolving roles of urology and medical oncology in the management of localized bladder cancer.
9. Discuss the recent advances in multi-modality evaluation and management of early stage of prostate cancer.
10. Discuss the biology and evolving therapeutics for advanced prostate cancer.

Physician: $150  
Resident and Fellow: $50  
Physician Assistant: $50  
Nurse Practitioner: $50  
Nurse: $50  
Allied Health Professional: $50
Medical Student: $50
Industry Professional: $200

In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education(ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.



Credit Designation Statement:

  

This activity was planned by and for the healthcare team and learners will receive 10.50 Interprofessional Continuing Education (IPCE) credits for learning and change.

 

Physicians: MedStar Health designates this live activity for a maximum of 10.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Board of Internal Medicine MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Surgery CC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

MOC Participation Threshold
Learner participates by writing a reflective statement and makes a commitment to change or maintain an element of practice.

Nurses: This activity is approved for 10.50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ Physician (10.50 hours), Nurse - ANCC (10.50 hours), Non-Physician Member of the Healthcare Team (10.50 hours), IPCE (10.50 hours), ABIM MOC Part 2 (10.50 hours), ABS CC (10.50 hours)

Washington Marriott Georgetown 
1221 22nd St NW
Washington, DC 20037
(202) 872-1500
Hotel Website

Mitigation of Relevant Financial Relationships

MedStar Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.

Individuals in a position to control the content of this CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible companies. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed below have been mitigated prior to the commencement of the activity.

If you are interested in supporting the program, please contact Elizabeth Romano at [email protected]